Literature DB >> 10476207

Variation in the immune response to adenoviral vectors in the brain: influence of mouse strain, environmental conditions and priming.

Y Ohmoto1, M J Wood, H M Charlton, K Kajiwara, V H Perry, K J Wood.   

Abstract

E1-deleted adenoviral vectors expressing the bacterial beta-galactosidase gene were inoculated into the brain of unprimed and primed C3H.He or C57BL/6J mice housed under either conventional or specific-pathogen-free (SPF) conditions. The kinetics of immune responses to both the vector and the transgene were investigated. In mice previously sensitized to adenovirus, the leukocyte infiltrate in the brain was dominated by CD8+ T cells, whereas in unprimed mice CD4+ T cells were present at higher levels. As expected, antibody titres to both adenovirus and beta-galactosidase were higher in primed mice than in unprimed mice after intracranial inoculation. C3H.He mice consistently made higher antibody responses than C57BL/6J mice. Although adenoviral vectors induced an inflammatory response under all conditions, mice housed in SPF facilities exhibited less inflammation than conventional mice and transgene expression persisted for longer. Irrespective of whether the mice had been deliberately primed to adenovirus, antibody titres were consistently lower in SPF mice compared with conventional mice. This study clearly demonstrates that environmental conditions, as well as previous priming to adenovirus, will affect both the quality and duration of the immune response triggered by gene delivery to the brain.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10476207     DOI: 10.1038/sj.gt.3300851

Source DB:  PubMed          Journal:  Gene Ther        ISSN: 0969-7128            Impact factor:   5.250


  9 in total

Review 1.  Nonneurotropic adenovirus: a vector for gene transfer to the brain and gene therapy of neurological disorders.

Authors:  Pedro R Lowenstein; Donata Suwelack; Jinwei Hu; Xianpeng Yuan; Maximiliano Jimenez-Dalmaroni; Shyam Goverdhana; Maria G Castro
Journal:  Int Rev Neurobiol       Date:  2003       Impact factor: 3.230

Review 2.  Microglial priming in neurodegenerative disease.

Authors:  V Hugh Perry; Clive Holmes
Journal:  Nat Rev Neurol       Date:  2014-03-18       Impact factor: 42.937

3.  Reversible demyelination, blood-brain barrier breakdown, and pronounced neutrophil recruitment induced by chronic IL-1 expression in the brain.

Authors:  Carina C Ferrari; Amaicha M Depino; Federico Prada; Nara Muraro; Sandra Campbell; Osvaldo Podhajcer; V Hugh Perry; Daniel C Anthony; Fernando J Pitossi
Journal:  Am J Pathol       Date:  2004-11       Impact factor: 4.307

4.  Senescent BALB/c mice are able to develop resistance to Leishmania major infection.

Authors:  Jan Ehrchen; Anca Sindrilaru; Stephan Grabbe; Frank Schönlau; Christian Schlesiger; Clemens Sorg; Karin Scharffetter-Kochanek; Cord Sunderkötter
Journal:  Infect Immun       Date:  2004-09       Impact factor: 3.441

5.  Gene transfer into rat brain using adenoviral vectors.

Authors:  Mariana Puntel; Kurt M Kroeger; Nicholas S R Sanderson; Clare E Thomas; Maria G Castro; Pedro R Lowenstein
Journal:  Curr Protoc Neurosci       Date:  2010-01

6.  Long-term impact of systemic bacterial infection on the cerebral vasculature and microglia.

Authors:  Ursula Püntener; Steven G Booth; V Hugh Perry; Jessica L Teeling
Journal:  J Neuroinflammation       Date:  2012-06-27       Impact factor: 8.322

Review 7.  Lifetime Modulation of the Pain System via Neuroimmune and Neuroendocrine Interactions.

Authors:  Ihssane Zouikr; Bianka Karshikoff
Journal:  Front Immunol       Date:  2017-03-13       Impact factor: 7.561

Review 8.  Microglia and macrophages of the central nervous system: the contribution of microglia priming and systemic inflammation to chronic neurodegeneration.

Authors:  V Hugh Perry; Jessica Teeling
Journal:  Semin Immunopathol       Date:  2013-06-04       Impact factor: 9.623

Review 9.  Microglial Phenotypes and Their Relationship to the Cannabinoid System: Therapeutic Implications for Parkinson's Disease.

Authors:  Rachel Kelly; Valerie Joers; Malú G Tansey; Declan P McKernan; Eilís Dowd
Journal:  Molecules       Date:  2020-01-21       Impact factor: 4.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.